Update on Funding & Suspension of Trading

AI SummaryClose X

Trellus Health plc has requested a suspension of trading on AIM due to ongoing uncertainty regarding its financial position and limited working capital. While the company has extended its cash runway to mid-June 2026 through cost-saving measures, including compensation reductions and vendor contract renegotiations, it has not yet secured long-term funding. The Board is evaluating all options, including the potential sale of its US subsidiary, Trellus Health Inc., and has engaged corporate restructuring advisers to protect stakeholder interests.

Disclaimer*

UK 100

Latest directors dealings